KA06.Z

ICD-11 MMS 2026-01

Fetus or newborn affected by unspecified noxious influence transmitted via placenta or breast milk

Coding note

These codes are for use when the listed maternal conditions are specified as the cause of confirmed morbidity or potential morbidity which have their origin in the perinatal period (before birth through the first 28 days after birth). Use additional code to identify the condition in the fetus or newborn.

Coding note from above levels

Conditions arising in the perinatal period, even though death or morbidity occurs later, should, as far as possible, be coded to chapter 19, which takes precedence over chapters containing codes for diseases by their anatomical site. For children less than 28 days old, assume that a reported condition developed in the perinatal period, unless the duration is stated and the onset was after the first completed week of life.

Exclusions from above levels

  • 20 – congenital malformations
  • KA87.4 – Neonatal hyperbilirubinaemia due to drugs or toxins transmitted from mother
  • 01 – Certain infectious or parasitic diseases - acquired after birth
Show allHide
  • 02 – Neoplasms
  • 05 – Endocrine, nutritional or metabolic diseases
  • 08 – Certain congenital diseases of the nervous system
  • 20 – Congenital malformations, deformations and chromosomal abnormalities
  • 22 – Injury, poisoning or certain other consequences of external causes
  • 3A10 – Hereditary haemolytic anaemia
  • 4A01.03 – Transient hypogammaglobulinaemia of infancy
  • 9B71.3 – Retinopathy of prematurity
  • BC43 – congenital cardiomyopathy
  • DA93.0 – Paralytic ileus
  • EA50.Z – Pemphigus neonatorum
  • EH40.00 – Cradle cap
  • http://id.who.int/icd/entity/588616678 – Gastroenteritis or colitis of infectious origin
  • http://id.who.int/icd/entity/609214049 – Congenital gonococcal infection

Sibling codes

  • KA06.0 – Fetus or newborn affected by maternal anaesthesia or analgesia in pregnancy, labour or delivery
  • KA06.1 – Fetus or newborn affected by maternal use of tobacco
  • KA06.2 – Fetus or newborn affected by maternal use of alcohol
  • KA06.3 – Fetus or newborn affected by maternal use of drugs of addiction
  • KA06.4 – Fetus or newborn affected by maternal use of nutritional chemical substances
  • KA06.5 – Fetus or newborn affected by maternal exposure to environmental chemical substances
  • KA06.Y – Fetus or newborn affected by other specified noxious influence transmitted via placenta or breast milk

Foundation entity

Fetus or newborn affected by noxious influences transmitted via placenta or breast milk – http://id.who.int/icd/entity/15547686

Allowed postcoordination axes

Part of: KA06: Fetus or newborn affected by noxious influences transmitted via placenta or breast milk › 19: Certain conditions originating in the perinatal period